OxTalks is Changing
OxTalks will soon be transitioning to Oxford Events (full details are available on the Staff Gateway). A two-week publishing freeze is expected in early Hilary to allow all events to be migrated to the new platform. During this period, you will not be able to submit or edit events on OxTalks. The exact freeze dates will be confirmed as soon as possible.
If you have any questions, please contact halo@digital.ox.ac.uk
Name: Keely Jones
Alzheimer’s Research UK Oxford Drug Discovery Institute
Events this person is hosting:
Monday 2 October 2017
Cross study analysis highlights endothelial and microglial transcriptomic components of AD risk
Date: 2 October 2017, 11:30 - 12:30
Speaker
:
Dr Ben Logsdon (Sage Bionetworks)
Venue: NDM Building, Headington OX3 7FZ
Venue Details: Seminar Room, Basement
Organiser:
Dr Caleb Webber, MRC Programme Leader (Department of Physiology, Anatomy and Genetics, University of Oxford)
Host:
Keely Jones (Alzheimer’s Research UK Oxford Drug Discovery Institute)
Thursday 26 October 2017
From Big Data to Smart Data. Quantitative Systems Pharmacology as a novel mechanism-based computer-modeling approach to support CNS Research & Development
Date: 26 October 2017, 9:30 - 10:30
Speaker
:
Hugo Geerts (co-founder and Chief Scientific Officer of In Silico Biosciences)
Venue: NDM Building, Headington OX3 7FZ
Venue Details: Seminar room (basement)
Organiser:
Professor Simon Lovestone, (Dept of Psychiatry, University of Oxford)
Host:
Keely Jones (Alzheimer’s Research UK Oxford Drug Discovery Institute)
Events this person is organising:
Monday 6 November 2017
Synaptic and immune system changes in the brains of mice with rising amyloid beta. Can we improve mouse models for Alzheimer's disease?
Date: 6 November 2017, 14:00 - 15:00
Speaker
:
Professor Frances Edwards (University College London (UCL))
Venue: NDM Building, Headington OX3 7FZ
Venue Details: Basement Seminar Room
Organiser:
Keely Jones (Alzheimer’s Research UK Oxford Drug Discovery Institute)
Host:
Dr John Davis (Alzheimer’s Research UK Oxford Drug Discovery Institute)
